Table 1. Patients' clinical and molecular features.
POMT1 mutations | |||||||
---|---|---|---|---|---|---|---|
Patient | Disease onset (years) | Current age | Phenotype | Mentation/brain MRI | Cardiomyopathy onset (years) | Nucleotide change | Amino-acid change |
1 | Birth | 17 | CMD-MR | MR/ microcephaly | 17 | c.2005G>A c.1241+1G>A | p.Ala699Thr p.His384_Thr414del |
2 | 3 | 20 | LGMD-MR | Slight MR/ normal | 12 | c.430A>G c.1241C>T | p.Asn144Asp p.Thr414Met |
3 | 33 | 34 | LGMD-NORM | Normal/normal | 34 | c.1864C>T r(=,1052_1053insGTAAG) | p.Arg622* =, p.Ile351Metfs15 |
Abbreviations: CMD-MR, congenital muscular dystrophy with mental retardation; LGMD-MR, limb-girdle muscular dystrophy with mental retardation; LGMD-NOMR, LGMD with no mental retardation; MR, mental retardation; MRI, magnetic resonance imaging; POMT1, protein-o-mannosyltransferase 1.